Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic lupus erythematosus (SLE), providing further evidence that the emerging ...

CAR-T therapies have been around for six years, but it was only in January that Bristol Myers Squibb unveiled the first positive readout for such a personalized immunotherapy in chronic lymphocytic ...

“Bharatiya Mazdoor Sangh’s (BMS) year-long celebration is not just been a ritual, it is a moment to look back and introspect: how BMS began, what motivated it, what it achieved, and what lies ahead.

Bristol Myers Squibb is paying Prime Medicine $110 million upfront to develop reagents for ex vivo T-cell therapies. Prime, which could receive a whopping $3.5 billion in milestones, disclosed the ...

Hyundai Motor Group (HMG) said it planned to make its battery management system (BMS) available in all its forthcoming electric vehicles (EVs) to alleviate growing concerns over battery safety ...